CRIS Current Research Information System

MUSIANI, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.128
EU - Europa 4.423
AS - Asia 2.252
AF - Africa 273
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
OC - Oceania 1
Totale 12.083
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.111
GB - Regno Unito 1.337
VN - Vietnam 724
CN - Cina 720
DE - Germania 593
UA - Ucraina 563
SE - Svezia 549
IT - Italia 505
SG - Singapore 438
IN - India 260
FR - Francia 193
RU - Federazione Russa 189
IE - Irlanda 172
EE - Estonia 93
ZA - Sudafrica 88
CH - Svizzera 81
TG - Togo 78
SC - Seychelles 53
BG - Bulgaria 41
JP - Giappone 37
BE - Belgio 31
IR - Iran 30
NG - Nigeria 30
CI - Costa d'Avorio 24
GR - Grecia 17
FI - Finlandia 16
JO - Giordania 16
CA - Canada 14
RO - Romania 12
NL - Olanda 11
AT - Austria 10
UZ - Uzbekistan 8
LB - Libano 7
EU - Europa 4
IQ - Iraq 3
HK - Hong Kong 2
IL - Israele 2
PL - Polonia 2
PR - Porto Rico 2
AR - Argentina 1
CL - Cile 1
CZ - Repubblica Ceca 1
ES - Italia 1
HU - Ungheria 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
MD - Moldavia 1
MT - Malta 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 12.083
Salva come PNG Salva come JPEG
Città #
Southend 1.162
Chandler 541
Dong Ket 501
Ashburn 492
Fairfield 455
Jacksonville 430
Singapore 379
Wilmington 260
Princeton 246
Ann Arbor 237
Woodbridge 236
Seattle 227
Houston 214
Dublin 172
Boardman 164
Cambridge 160
Westminster 119
Padova 118
Nanjing 106
Berlin 94
Santa Clara 86
Medford 79
Lomé 78
Bern 74
Mülheim 69
Saint Petersburg 66
New York 54
Milan 53
Mahé 52
Jinan 48
Shenyang 48
Sofia 41
Redwood City 40
Nanchang 37
Tokyo 37
Beijing 34
Changsha 34
Brussels 31
Abeokuta 30
Tianjin 30
Bologna 29
Hebei 28
Florence 26
Verona 26
Abidjan 24
Bremen 24
Hangzhou 24
Jiaxing 23
Des Moines 21
Zhengzhou 21
Olalla 20
San Diego 20
Guangzhou 19
Dearborn 17
Paris 17
Taizhou 17
Amman 16
Helsinki 16
Norwalk 16
Ningbo 14
Shanghai 14
Kunming 13
San Venanzo 13
Haikou 12
Rome 12
Taiyuan 12
Falls Church 11
Hyderabad 11
Kuban 11
Los Angeles 11
Pune 11
Ardabil 10
Tappahannock 10
Toronto 10
Lanzhou 9
Bühl 8
Leawood 8
Monmouth Junction 8
Mountain View 8
Wuhan 8
Fuzhou 7
Phoenix 7
Shenzhen 7
Vienna 7
Zanjan 7
Andover 6
Changchun 6
Hefei 6
Quanzhou 6
Rimini 6
Augusta 5
Catania 5
Chengdu 5
Chongqing 5
Frankfurt Am Main 5
Stockholm 5
Turin 5
Washington 5
Buffalo 4
Edinburgh 4
Totale 8.075
Salva come PNG Salva come JPEG
Nome #
A new primer set improves the efficiency of competitive PCR-ELISA for the detection of B19 DNA 186
Bio- and chemiluminescence imaging in analytical chemistry 158
Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis 155
Presence of high-risk mucosal human papillomavirus genotypes in primary melanoma and in acquired dysplastic melanocytic naevi 154
A miniaturized multiplexed analytical device with chemiluminescence "contact" imaging detection for diagnostic applications 154
Assessment of the presence of mucosal human papillomaviruses in malignant melanomas using combined fluorescent in situ hybridization and chemiluminescent immunohistochemistry 154
Analisi dell’integrazione del DNA di HPV16 in campioni cervicali, mediante PCR qualitativa e quantitativa 153
Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus 149
Bio-chemiluminescent miniaturized biosensors 146
A proteomic approach to the analysis of B19 capsid proteins 145
Presence and type of oncogenic human papillomavirus in classic and in differentiated vulvar intraepithelial neoplasia and keratinizing vulvar squamous cell carcinoma 141
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 140
Analysis of HPV16 E6*I-II transcripts in cervical samples 140
Analysis by real-time PCR of B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines 138
Analysis of Parvovirus B19 DNA methylation status in experimental and natural infections. 138
Infezione da Parvovirus B19 nella donna in gravidanza, nel feto e nel neonato. 136
High-throughput polymerase chain reaction chemiluminescent enzyme immunoassay for typing and quantifying human papillomavirus DNAs 134
Efficient treatment of paraffin-embedded cervical tissue for HPV DNA testing by HC-II and PCR assays 133
Combined fluorescent DNA in situ hybridization and chemiluminescent immunohistochemistry for the co-localization of mucosal human papillomavirus and malignant melanoma 133
Sviluppo di un saggio di Real- Time PCR per la quantificazione del DNA di HPV in campioni citologici cervicali 133
Ricerca e determinazione del carico virale di parvovirus B19 mediante tecnica di Real-time PCR calibrata 131
Analisi della competenza funzionale di cloni genomici di parvovirus B19 130
Comparative evaluation of an automated assay for parvovirus B19 antibody detection 128
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicale in situ 127
Analysis of E6* spliced products of HPV16 as molecular markers of cervical disease progression. 125
Recurrent erythema in patients with long-term parvovirus B19 infection 124
Application of the NASBA method for the detection of human papillomavirus E6-E7 transcripts in patients treated for high grade CIN and positive to HPV16 123
Analysis of splice junctions and polyadenylation sites of parvovirus B19 genome by a PCR-based approach 123
Ricerca del parvovirus B19 nello screening per la sicurezza degli emoderivati 122
Carica virale, integrazione ed espressione degli oncogeni di HPV16: implicazioni nella progressione della patologia cervicale 122
Analisi del DNA di HPV 16 e degli mRNA E6/E7 in campioni citologici cervicali 122
Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias 121
Disruption of HPV 16 E1 and E2 genes in precancerous cervical lesions 119
Diagnosis of fetal parvovirus B19 infection: value of virological assays in fetal specimens. 119
Correlazione tra presenza del DNA di HPV ed espressione della P16INK4A in lesioni benigne e maligne della vulva 118
Analisi funzionale del genoma di parvovirus B19 in due sistemi sperimentali: infezione in vitro e trasfezione con cloni ricombinanti 118
Calibrated real-time PCR for evaluation of parvovirus b19 viral load 118
Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. 117
Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids 114
Presenza e ruolo della metilazione dei dinucleotidi CpG nel DNA di parvovirus B19. 114
Chemiluminescent assay for p16INK4A quantitation in cervical biopsies combined with fluorescent HPV DNA in situ hybridisation 113
Analisi della competenza funzionale di cloni genomici di parvovirus B19 per lo sviluppo di vettori virali 113
High-throughput two-step LNA real time PCR assay for the quantitative detection and genotyping of HPV prognostic-risk groups. 112
Presence and type of oncogenic human papillomavirus in classic VIN, differentiated VIN and keratinizing VSCC 111
Functional analysis and quantitative determination of the expression profile of human parvovirus B19 111
B19 in vitro infection of permissive systems: a quantitative analysis of virus replication and expression 111
HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ 111
Determination of physical status and viral load of HPV 16 DNA in cytological cervical samples by quantitative PCR assays 110
Evidence of human bocavirus viremia in healthy blood donors. 109
Analysis of the functional competence of genomic clones of Parvovirus B19 108
Molecular luminescence imaging 107
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 107
Analisi di trascritti virali di HPV16 come indicatori di carcinoma cervicali in situ 107
Rivelazione e caratterizzazione di varianti genotipiche di parvovirus B19 in sangue proveniente da unità trasfusionale 106
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors 106
Qualitative PCR-ELISA protocol for the detection and typing of viral genomes. 105
Espressione e purificazione di gamma-interferon bovino bioattivo in baculovirus 104
Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment 104
Quantitative immunohistochemistry and in situ hybridization with luminescence detection: a new potential diagnostic tool 103
Parvovirus B19 genome as a single, two-state replicative and transcriptional unit 103
Evaluation of quantitative PCR assays for the determination of physical status and viral load of HPV16 DNA 102
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 102
Molecular analysis of HPV 16 E6I/E6II spliced mRNAs and correlation with the viral physical state and the grade of the cervical lesion. 98
Parvovirus B19 infection during pregnancy and evaluation of fetal outcomes 98
Human papillomavirus in melanoma: reply from authors 98
Follow up of patients treated of HPV 16 high-grade CIN: HPV DNA patterns and disease implication 97
Parvovirus B19-derived fetal complications following gestational infection. 97
Catalytic partial oxidation of CH4-H2mixtures over Ni foams modified with Rh and Pt 97
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la colocalizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 96
Parvovirus B19 DNA Is Commonly Harboured in Human Skin. 96
Meningoencephalitis with persistent parvovirus B19 infection in an apparently healthy woman 94
Metodo di real time PCR in due step per la definizione di gruppi di rischio di HPV e per la quantificazione genotipo specifica 93
Correlazione tra presenza di HPV, carica e integrazione virale in lesioni (pre)neoplastiche vulvari 91
Valutazione del rischio di insorgenza di nefropatia associata a polyomavirus nello screening di trapiantati renali 90
HepG2 hepatocellular carcinoma cells are a non-permissive system for B19 virus infection. 89
Detection of parvovirus B19 IgG: choice of antigens and serological tests 89
Valutazione della correlazione tra presenza di HPV ed espressione della P16 INK4A in lesioni vulvari e cervicali mediante FISH combinata ad IHC con rivelazione chemiluminescente 88
Implicazioni nella progressione della patologia cervicale 88
Quantitative evaluation of HBoV DNA in serum samples from Italian population. 88
Diagnosi virologica di infezione da papillomavirus umani 87
Comparison of abbott realtime HPV assay and digene HC2 HPV DNA test for the detection of high-risk HPV DNA in a referral population setting Source: JOURNAL OF CLINICAL VIROLOGY Volume: 46 Pages: S49-S49 Supplement: Suppl. 1 Published: SEP 2009 87
Studio dell’espressione di parvovirus B19 in sistemi permissivi e non mediante real-time PCR 87
Detection of HPV 16 E6-E7 transcripts in cervical cytological samples and correlation with HPV-DNA physical status 85
Development of a miniaturized analytical device employing luminescence “contact” imaging detection for parvovirus B19 infection diagnosis 85
Colorimetric and chemiluminescent Peptide Nucleic Acid-based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 85
Valutazione della persistenza di diversi genotipi di HPV nel follow-up di pazienti trattate per lesioni cervicali di alto gradi 84
Persistent parvovirus B19 infection resulting in carpal tunnel syndrome 84
Multiplex chemiluminescence microscope imaging of P16INK4A and HPV DNA as biomarker of cervical neoplasia 83
Functional analysis of B19 virus genome by transcript-specific quantitative real-time PCR 82
PNA-Based in situ hybridisation assay for the detection and quantification of parvovirus B19 nucleic acids 79
Clonazione, espressione e purificazione di g-IFN bovino ricombinante in baculovirus 79
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 78
Quantitative immunohistochemistry and in situ hybridisation imaging procedures with luminescence detection: a new potential diagnostic tool 76
Nuovo saggio FISH per la ricerca del DNA di HPV combinato ad IHC chemiluminescente per la quantificazione di p16 INK4A in lesioni cervicali 76
Sviluppo di un metodo di ibridazione in situ fluorescente e immunoistochimica chemiluminescente combinate per la co-localizzazione di DNA di papillomavirus umano e di un marker melanocitico tumorale 75
Prevention of iatrogenic transmission of B19 infection: different approaches to detect, remove or inactivate virus contamination 75
Quantitative immunohistochemistry and in situ hybridization imaging procedures with luminescence detection: a new potential diagnostic tool 73
PNA-based probe for quantitative chemiluminescent in situ hybridisation imaging of cellular parvovirus B19 replication kinetics 73
Ricerca di HPV ad alto rischio oncogeno: Abbott Real Time HPV Assay e Digene HC2 HPV DNA Test a confronto 73
B19 virus replication and expression patterns in primary bone marrow and myeloblastoid cell lines – a quantitative analysis by real-time PCR 72
Totale 10.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.758 0 0 0 0 205 244 260 358 270 189 90 142
2020/20212.071 385 108 48 99 26 125 37 106 121 107 108 801
2021/20222.130 164 110 140 224 179 116 22 116 67 226 354 412
2022/20232.297 247 339 126 272 177 139 57 137 358 45 236 164
2023/2024798 42 94 39 128 44 165 108 63 18 33 21 43
2024/20251.039 80 359 221 144 235 0 0 0 0 0 0 0
Totale 12.336